Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Varenicline for smoking cessation: a narrative review of efficacy, adverse effects, use in at-risk populations, and adherence
Jon O. Ebbert, Michael V. Burke, J. Taylor Hays
Patient Preference and Adherence (2016), pp. 435-435
Open Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

A systematic review on the anti-microbial activities and structure-activity relationship (SAR) of quinoxaline derivatives
Sri Mounika Bellapukonda, Rani Bandela, Anuradha Singampalli, et al.
European Journal of Medicinal Chemistry (2025) Vol. 289, pp. 117472-117472
Closed Access | Times Cited: 1
Prevalence and determinants of cigarette smoking relapse among US adult smokers: a longitudinal study
Ahmed Alboksmaty, Israel T. Agaku, Satomi Odani, et al.
BMJ Open (2019) Vol. 9, Iss. 11, pp. e031676-e031676
Open Access | Times Cited: 37
Medical Therapy for Peripheral Artery Disease
Mario Enrico Canonico, Connie N. Hess, R. Kevin Rogers, et al.
Current Cardiology Reports (2024) Vol. 26, Iss. 6, pp. 651-659
Closed Access | Times Cited: 4
Pharmacological Treatments for Methamphetamine Use Disorder: Current Status and Future Targets
Justin R. Yates
Substance Abuse and Rehabilitation (2024) Vol. Volume 15, pp. 125-161
Open Access | Times Cited: 4
Use of low-dose varenicline in patients who do not tolerate standard-dose varenicline: A longitudinal case series
Mark E. Swanson, Luisa Masclans, James M. Davis
Tobacco Prevention & Cessation (2025) Vol. 11, Iss. March, pp. 1-6
Open Access
IUPHAR-review: The integration of classic psychedelics into current substance use disorder treatment models
David B. Yaden, Andrea Berghella, Peter S. Hendricks, et al.
Pharmacological Research (2023) Vol. 199, pp. 106998-106998
Open Access | Times Cited: 7
The Relative Value of Anti-Obesity Medications Compared to Similar Therapies
Nina Kim, Joaquin J. Estrada, Isabella Chow, et al.
ClinicoEconomics and Outcomes Research (2023) Vol. Volume 15, pp. 51-62
Open Access | Times Cited: 5
Impact of early nausea on varenicline adherence and smoking cessation
Annie R. Peng, Walter Swardfager, Neal L. Benowitz, et al.
Addiction (2019) Vol. 115, Iss. 1, pp. 134-144
Open Access | Times Cited: 15
Choice of smoking cessation products among people with substance use problems in the US: Findings from the Population Assessment of Tobacco and Health (PATH) study Wave 6
Olufemi Erinoso, Theresa Watts, Stephanie M. Koning, et al.
Addictive Behaviors (2024) Vol. 158, pp. 108104-108104
Closed Access | Times Cited: 1
Social Influences on Nicotine-Related Behaviors
José Antonio López Pina, Mark D. Namba, Jonna M. Leyrer‐Jackson, et al.
International review of neurobiology (2018), pp. 1-32
Closed Access | Times Cited: 8
The risk of varenicline-induced seizure among those who have attempted to quit smoking using pharmacotherapy
Divyan Chopra, Anuj Shah, Aisha Vadhariya, et al.
Epilepsy & Behavior (2019) Vol. 97, pp. 169-173
Closed Access | Times Cited: 6
ADHD symptoms and smoking outcomes in a randomized controlled trial of varenicline for adolescent and young adult tobacco cessation
ReJoyce Green, Nathaniel L. Baker, Pamela L. Ferguson, et al.
Drug and Alcohol Dependence (2023) Vol. 244, pp. 109798-109798
Open Access | Times Cited: 2
Pharmacological secondary prevention in patients with mesenterial artery atherosclerosis and arterial embolism
Anders Gottsäter
Best Practice & Research Clinical Gastroenterology (2016) Vol. 31, Iss. 1, pp. 105-109
Closed Access | Times Cited: 4
It Only Affects Me: Pharmaceutical Regulation and Harm to Others
Connor K. Kianpour
HEC Forum (2020) Vol. 34, Iss. 3, pp. 269-289
Closed Access | Times Cited: 4
Behavioral therapy and pharmacotherapy: A case report on right approach for tobacco cessation
Avnica Agarwal, Mayank Das, PannaLal Jaiswal, et al.
Journal of Cancer Research and Therapeutics (2022) Vol. 19, Iss. Suppl 1, pp. S439-S442
Open Access | Times Cited: 3
A retrospective analysis of the comparative effectiveness of smoking cessation medication among individuals with mental illness in community‐based mental health and addictions treatment settings
Chizimuzo T.C. Okoli, Amanda T. Wiggins, Amanda Fallin‐Bennett, et al.
Journal of Psychiatric and Mental Health Nursing (2017) Vol. 24, Iss. 8, pp. 610-619
Closed Access | Times Cited: 3
Incremental net monetary benefit of using varenicline for smoking cessation: A systematic review and meta‐analysis of economic evaluation studies
Chayutthaphong Chaisai, Chanthawat Patikorn, Kednapa Thavorn, et al.
Addiction (2024) Vol. 119, Iss. 7, pp. 1188-1202
Closed Access
Combination Treatment With Varenicline and Nicotine Patch on Smoking Cessation Outcomes in Heavy Drinkers at 26-Week Follow-up
L Robinson, Nathan Didier, Riya Thomas, et al.
Journal of Clinical Psychopharmacology (2024)
Closed Access
Google Trends analysis of keywords related to smoking and smoking cessation during the COVID-19 pandemic in four European countries (Preprint)
Tobias Jagomast, Jule Finck, Imke Tangemann-Münstedt, et al.
Online Journal of Public Health Informatics (2024) Vol. 16, pp. e57718-e57718
Open Access
Anti-smoking intervention, e-cigarettes, and heated tobacco products – what to remember? Recommendations for doctors who have direct contact with nicotine-addicted patients regarding anti-smoking intervention
Dorota Kaleta, Beata Świątkowska, Michał Szulc, et al.
Medycyna Ogólna i Nauki o Zdrowiu (2024)
Open Access
The Effect of Varenicline on Smoking Cessation in Hospitalized Patients: A Systematic Review and Meta-Analysis
Mahshid Aryanpur, Raheb Ghorbani, Sajjad Rashno, et al.
Addiction and Health (2024) Vol. 16, Iss. 2, pp. 122-129
Open Access
Disorders Due to Substance Use: Nicotine
Douglas Ziedonis, Cezar Cimpeanu, Amy Bachyrycz, et al.
Springer eBooks (2024), pp. 2729-2779
Closed Access
Slow-release L-Cysteine (Acetium®) Lozenge Is an Effective New Method in Smoking Cessation. A Randomized, Double-blind, Placebo-controlled Intervention
Karí Syrjänen, Katja Eronen, Panu Hendolin, et al.
Anticancer Research (2017) Vol. 37, Iss. 7
Open Access | Times Cited: 2
Counseling Effect on Smoking Cessation Behavior in Junior High School Students
Amsal Amsal, Kadar Ramadhan, Nurfatimah Nurfatimah, et al.
Media Kesehatan Masyarakat Indonesia (2021) Vol. 17, Iss. 1, pp. 9-16
Open Access | Times Cited: 2
Disorders Due to Substance Use: Nicotine (Including Tobacco and Vaping)
Douglas Ziedonis, Cezar Cimpeanu, Amy Bachyrycz, et al.
Springer eBooks (2023), pp. 1-51
Closed Access
Page 1 - Next Page

Scroll to top